Patents by Inventor Anne Fagan Niven

Anne Fagan Niven has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ALZHEIMER'S DISEASE BIOMARKERS AND METHODS OF USE
    Publication number: 20110143380
    Abstract: The invention encompasses biomarkers for AD, a method for detecting AD, a method of monitoring AD, and a kit for quantifying biomarkers for AD.
    Type: Application
    Filed: November 24, 2010
    Publication date: June 16, 2011
    Applicant: THE WASHINGTON UNIVERSITY
    Inventors: David Holtzman, Yan Hu, Robert Reid Townsend, Richard J. Perrin, Anne Fagan Niven, Rebecca Craig-Schapiro
  • METHODS TO TREAT ALZHEIMER'S DISEASE OR OTHER DISORDERS MEDIATED BY AMYLOID-BETA ACCUMULATION IN A SUBJECT
    Publication number: 20090264355
    Abstract: The invention provides methods of delaying the onset, slowing the progression, preventing, or treating Alzheimers disease in a subject. In particular, the invention provides methods of modulating transport of A? across the blood brain barrier of the subject.
    Type: Application
    Filed: October 11, 2006
    Publication date: October 22, 2009
    Applicant: WASHINGTON UNIVERSITY IN ST. LOUIS
    Inventors: David Holtzman, David Piwnica-Worms, John R. Cirrito, Anne Fagan Niven
  • Predictive diagnostic for Alzheimer's disease
    Patent number: 6465195
    Abstract: A diagnostic method for identifying individuals at risk for developing Alzheimer's disease is disclosed. The method relies on elevated levels of the ratio of A&bgr;40/A&bgr;42 associated with lipoproteins in the cerebrospinal fluid of individuals at risk as compared to this ratio in the overall population.
    Type: Grant
    Filed: December 29, 2000
    Date of Patent: October 15, 2002
    Assignee: Washington University
    Inventors: David M. Holtzman, Anne Fagan Niven
  • Predictive diagnostic for alzheimer's disease
    Publication number: 20010044126
    Abstract: A diagnostic method for identifying individuals at risk for developing Alzheimer's disease is disclosed. The method relies on elevated levels of the ratio of A&bgr;40/A&bgr;42 associated with lipoproteins in the cerebrospinal fluid of individuals at risk as compared to this ratio in the overall population.
    Type: Application
    Filed: December 29, 2000
    Publication date: November 22, 2001
    Inventors: David M. Holtzman, Anne Fagan Niven